tiprankstipranks
Trending News
More News >

Bio-Techne price target lowered to $70 from $95 at UBS

UBS lowered the firm’s price target on Bio-Techne (TECH) to $70 from $95 and keeps a Buy rating on the shares. Bio-Techne’s update reflects heightened market challenges, but it “could have been worse,” the analyst tells investors in a research note.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue